Effect of Alveolar Ridge Preservation on Implant Esthetic Outcomes

NCT ID: NCT02507661

Last Updated: 2018-03-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-06-30

Study Completion Date

2018-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate esthetic outcome of implant supported single crowns after alveolar ridge preservation with beta three calcium phosphate with collagen type I in aesthetic region in upper jaw.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Partial Edentulism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

alveolar ridge preservation - 2 months

preservation of alveolar ridge with beta tricalcium phosphate + collagen - 2 months

Group Type EXPERIMENTAL

preservation of alveolar ridge with beta tricalcium phosphate + collagen - 2 months

Intervention Type DRUG

no-preservation of alveolar ridge - 2 months

no-preservation of alveolar ridge - 2 months

Group Type ACTIVE_COMPARATOR

no-preservation of alveolar ridge - 2 months

Intervention Type DRUG

preservation of alveolar ridge - 4 months

preservation of alveolar ridge with beta tricalcium phosphate + collagen - 4 months

Group Type EXPERIMENTAL

preservation of alveolar ridge with beta tricalcium phosphate + collagen - 4 months

Intervention Type DRUG

no-preservation of alveolar ridge - 4 months

no-preservation of alveolar ridge - 4 months

Group Type ACTIVE_COMPARATOR

no-preservation of alveolar ridge - 4 months

Intervention Type DRUG

preservation of alveolar ridge - 9 months

preservation of alveolar ridge with beta tricalcium phosphate + collagen - 9 months

Group Type EXPERIMENTAL

preservation of alveolar ridge with beta tricalcium phosphate + collagen - 9 months

Intervention Type PROCEDURE

no-preservation of alveolar ridge - 9 months

no-preservation of alveolar ridge - 9 months

Group Type ACTIVE_COMPARATOR

no-preservation of alveolar ridge - 9 months

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

preservation of alveolar ridge with beta tricalcium phosphate + collagen - 2 months

Intervention Type DRUG

no-preservation of alveolar ridge - 2 months

Intervention Type DRUG

preservation of alveolar ridge with beta tricalcium phosphate + collagen - 4 months

Intervention Type DRUG

no-preservation of alveolar ridge - 4 months

Intervention Type DRUG

preservation of alveolar ridge with beta tricalcium phosphate + collagen - 9 months

Intervention Type PROCEDURE

no-preservation of alveolar ridge - 9 months

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy patients according to Classification of American Society of Anesthesiologists (ASA I)
* presence of 4 socket walls
* non-smokers
* good oral hygiene
* good occlusion

Exclusion Criteria

* patients with alveolar ridge height less than 12 mm
* presence of acute or chronic oro-facial pain
* acute periapical infection
* injured soft tissue
* patients who had dental interventions in last 7 days
* patients who had any medications within last 24 hours
* patients with bruxism and para-functions
* patients with allergies to any of applied materials
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Belgrade

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bozidar Brkovic, DDS, MSc, PhD, Professor

DDS PhD Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bozidar M Brkovic, PhD

Role: PRINCIPAL_INVESTIGATOR

School of Dental Medicine, University of Belgrade

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

School of Dental Medicine, University of Belgrade

Belgrade, , Serbia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Serbia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

36/21

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.